The Conversation: André Hoffmann, vice-chairman and board member and Dr. Jörg Duschmalé, board member, Roche
Roche's founding family members on the future of healthcare and the family professional relationship.
roche
January 2023
May 2022
Roche launches 2-in-1 biotech drug for breast cancer in India
The two medicines prescribed together is a standard treatment regimen approved in over 100 countries for both early and metastatic HER2-positive breast cancer.
